Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer
PharmaShots
Top 20 R&D Spending Biopharma Companies of 2026
Top 20 R&D Spending Biopharma Companies of 2026 Shots: 20. Moderna R&D Expenditure: $3.13B Market Cap: $22.98B Founded Year: 2010 Total Employees: 4700 Headquarters: Massachusetts, United States Stock Exchange: NASDAQ 19. Vertex Pharmaceuticals R&D Expenditure: $3.9B Market Cap: $122.26B Founded Year: 1989 Total Employees: 6400 Headquarters: Massachusetts, United States Stock Exchange: NASDAQ 18. Takeda R&D Expenditure: $4.455B Market Cap: $55.57B Founded Year: 1781 Total Employees: 47000 Headquarters: Tokyo,… The post Top 20 R&D Spending Biopharma Companies of 2026 appeared first on PharmaShots.
Read Full Article
Pharma Tech
Sublingual semaglutide offered to UK practices despite Novo Nordisk concerns
Sublingual semaglutide, which does not hold marketing authorisation, is touted to minimise gastric issues.
Read Full Article
Pharma Tech
Boosting CGT access: a global consideration with wide-spanning benefits
Wider patient access to CGTs hinges on further infrastructure developments and the movement of therapies into the community setting.
Read Full Article
Pharma Tech
J&J ventures further into in vivo CAR-T space with Sail partnership, potential buyout
J&J strikes its deal with Sail as the in vivo CAR-T space becomes increasingly crowded, with several big pharma players betting on the class.
Read Full Article
Pharma Tech
miRecule and Rio Biofarma to develop RNA therapeutic delivery technologies
miRecule has signed a research collaboration with Rio Biofarma Brasil (RBBL) to co-develop peptide-mediated delivery technologies aimed at improving targeted RNA therapeutics delivery to tissues beyond the liver and muscles in a range of disease areas.
Read Full Article
Sponsored content
Featured promotional
News
Latest stories
PharmaShots
Jul 31, 2026, 1:30 PM
Top 20 R&D Spending Biopharma Companies of 2026
Top 20 R&D Spending Biopharma Companies of 2026 Shots: 20. Moderna R&D Expenditure: $3.13B Market Cap: $22.98B Founded Year: 2010 Total Employees: 4700 Headquarters: Massachusetts, United States Stock Exchange: NASDAQ 19. Vertex Pharmaceuticals R&D Expenditure: $3.9B Market Cap: $122.26B Founded Year: 1989 Total Employees: 6400 Headquarters: Massachusetts, United States Stock Exchange: NASDAQ 18. Takeda R&D Expenditure: $4.455B Market Cap: $55.57B Founded Year: 1781 Total Employees: 47000 Headquarters: Tokyo,… The post Top 20 R&D Spending Biopharma Companies of 2026 appeared first on PharmaShots.
PharmaShots
Jul 31, 2026, 12:30 PM
IMPACT Therapeutics Inks Exclusive Licensing Agreement with Pharmanovia for Senaparib in EMEA, Australia and New Zealand
Shots: Ref: PRNewsWire | Image: IMPACT Therapeutics & Pharmanovia | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post IMPACT Therapeutics Inks Exclusive Licensing Agreement with Pharmanovia for Senaparib in EMEA, Australia and New Zealand appeared first on PharmaShots.
PharmaShots
Jul 31, 2026, 11:30 AM
Daiichi Sankyo and AstraZeneca Report the EC Approval for Datroway to Treat Metastatic Triple Negative Breast Cancer
Shots: Ref: Daiichi Sankyo | Image: Daiichi Sankyo & AstraZeneca | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Daiichi Sankyo and AstraZeneca Report the EC Approval for Datroway to Treat Metastatic Triple Negative Breast Cancer appeared first on PharmaShots.
Pharma Tech
Jul 31, 2026, 10:57 AM
Sublingual semaglutide offered to UK practices despite Novo Nordisk concerns
Sublingual semaglutide, which does not hold marketing authorisation, is touted to minimise gastric issues.
PharmaShots
Jul 31, 2026, 10:30 AM
Kaigene Inks ~$378M Exclusive Licensing Agreement with Taisho Pharmaceutical for KG006 in Japan
Shots: Ref: PRNewsWire | Image: Kaigene & Taisho Pharmaceutical | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information connect with us at connect@pharmashots.com The post Kaigene Inks ~$378M Exclusive Licensing Agreement with Taisho Pharmaceutical for KG006 in Japan appeared first on PharmaShots.
Pharma Tech
Jul 31, 2026, 10:13 AM
Boosting CGT access: a global consideration with wide-spanning benefits
Wider patient access to CGTs hinges on further infrastructure developments and the movement of therapies into the community setting.
News
Latest industry coverage
Google News
Jul 31, 2026, 6:37 PM
Innovation Politics at the FDA - Petrie-Flom Center
Innovation Politics at the FDA Petrie-Flom Center
Google News
Jul 31, 2026, 6:13 PM
Pharma Innovation Drives Record Revenue in Q2 - PlasticsToday
Pharma Innovation Drives Record Revenue in Q2 PlasticsToday
Google News
Jul 31, 2026, 6:10 PM
Merck: Heading Into Q2 Earnings, The Keytruda Cliff Looks Increasingly Less Steep - Seeking Alpha
Merck: Heading Into Q2 Earnings, The Keytruda Cliff Looks Increasingly Less Steep Seeking Alpha
Google News
Jul 31, 2026, 5:52 PM
Insilico Medicine launches the industry’s first Drug Discovery and - Bioengineer.org
Insilico Medicine launches the industry’s first Drug Discovery and Bioengineer.org
Google News
Jul 31, 2026, 5:50 PM
TAPI Mexico Invests MX$140M in Oncology API Production - Mexico Business News
TAPI Mexico Invests MX$140M in Oncology API Production Mexico Business News
Google News
Jul 31, 2026, 5:08 PM
Pharmaceutical startup adds to board of directors, advances clinical trials - The Business Journals
Pharmaceutical startup adds to board of directors, advances clinical trials The Business Journals
Google News
Jul 31, 2026, 5:05 PM
Trump administration revises rebate pilot for 340B drug discount program, angering hospitals - STAT
Trump administration revises rebate pilot for 340B drug discount program, angering hospitals STAT
Google News
Jul 31, 2026, 5:05 PM
400 jobs coming to West Chester Twp. through $750M Resilience-Lilly expansion - Dayton Daily News
400 jobs coming to West Chester Twp. through $750M Resilience-Lilly expansion Dayton Daily News
Google News
Jul 31, 2026, 4:57 PM
Should You Be Able to Bet on Drug Trials? - The New York Times
Should You Be Able to Bet on Drug Trials? The New York Times
Sponsored placement
Featured promotions
Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer